首页> 外文OA文献 >Faculty Opinions recommendation of Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial.

【2h】

Faculty Opinions recommendation of Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial.

机译：教师意见提出的推荐肺癌患者糖尿病的发病率在De Novo肾移植受者中，接受延长释放的巨杆菌的免疫抑制，具有2种不同的皮质类固醇最小化策略：提前，随机对照试验。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Jean Francis;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial [J] . Mourad Georges, Glyda Maciej, Albano Laetitia, Transplantation: Official Journal of the Transplantation Society . 2017,第8期

机译：后翻盖糖尿病的发病率在Novo Novo肾移植受者接受延长释放的Tacolimus的免疫抑制，2种不同的皮质类固醇最小化策略：提前，随机对照试验
2. ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus [J] . Rummo Oleg O., Carmellini Mario, Rostaing Lionel, Transplant international : . 2017,第1期

机译：坚持：随机对照试验比较肾功能在De Novo肾移植受者接受延长释放的Tacrolimus加霉霉素或西罗莫司
3. IMPACT OF STEROID-FREE PROTOCOL ON INCIDENCE OF POSTTRANSPLANTATION DIABETES MELLITUS: A PROSPECTIVE, RANDOMIZED, MULTICENTER, OPEN-LABEL, CONTROLLED TRIAL IN RENAL TRANSPLANT RECIPIENTS (SAILOR STUDY) [J] . Ekberg Jana, Baid-Agrawal Seema, Jespersen Bente, Transplant international : . 2019,第S2期

机译：无异丙糖尿病患者发病率的影响：肾移植受者的前瞻性，随机，多中心，开放标签，对照试验（水手研究）
4. Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE A Randomized Controlled Trial [O] . Georges Mourad, Maciej Glyda, Laetitia Albano, -1

机译：在De Novo肾脏移植受者中接受延长释放他克莫司的免疫抑制并采用2种不同的糖皮质激素最小化策略的移植后糖尿病的发生率：ADVANCE一项随机对照试验
5. Incidence of posttransplantation diabetes mellitus in de novo kidney transplant recipients receiving prolonged-release tacrolimus-based immunosuppression with 2 different corticosteroid minimization strategies: ADVANCE, a randomized controlled trial [O] . Mourad, Georges, Glyda, Maciej, Albano, Laetitia, 2017

机译：从头开始接受基于他克莫司的免疫抑制并采用两种不同的糖皮质激素最小化策略的新生肾移植接受者的移植后糖尿病发生率：ADVANCE，一项随机对照试验

Faculty Opinions recommendation of Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial.

著录项

相似文献

相关主题

期刊订阅